International Consultant- Pharmacovigilance Systems Strengthening
NewAF_BWA Botswana
Closes 5 Nov 2026 CET (UTC+1)
Employers can close earlier.
..
1. Objectives |
The overall objective of engaging a consultant is to accelerate implementation of PV IDPs to attain ML3 for vigilance functions.
Specific Objectives 1. To conduct a comprehensive baseline GBT assessment, assist in review of guidelines, SOPs, assessment tools, GBT evidence and provide guidance essential for fulfilling the identified IDPs. 2. Integrate GBT IDP implementation to promote compliance by industry, public health entities and national regulatory requirements.
|
2. Scope of Work |
Output 1.1: Conduct a detailed landscape and SWOT analysis of vigilance systems within the BoMRA and related stakeholders in Botswana.
Output 1.2: Review guidelines, Standard Operating Procedures (SOPs) working tools, and regulatory actions and decisions aligned with WHO Global benchmarking standards.
Output 1.3: Provide review of - Evaluation of Risk Management Planning (RMP) and related documents - Safety Communication and Vigilance data Publication - Vigilance documents during conduct of Good Vigilance Inspections - Implementation of IDPs at Adverse Drug Reaction Monitoring Centres (AMCs) against the Field Visit Manual for Assessing the Performance of Vigilance Function
Output 1.4: Provide guidance on communication to BoMRA stakeholders on - Activities to be conducted to enhance understanding and compliance to regulations and guidelines
|
3. Deliverables: |
Advertisement
|
4. Qualifications, experience, skills and languages |
Qualifications Advanced degree in pharmacy, public health, regulatory science, or related field
Experience - Essential: Experience working in the medicine regulatory authority/agency and over 5 years of relevant work experience in pharmacovigilance, vaccine safety, benefit-risk aggregated report review and risk management planning with a focus on risk minimisation measures.
- Desirable: Experience with WHO Global Benchmarking Tools and/or ICH/EMA guidelines.
Skills/Knowledge - Expert in the field of: pharmacovigilance, vaccine safety and medicine risk management review.
Languages and level required - Fluent in English (spoken and written).
|
5. Technical Supervision |
On a day-to-day basis, the consultant will report to:
Overall contractual oversight will be provided by Dr. Fabian NDENZAKO, WHO Representative
|
6. Location |
On site: Botswana Medicines Regulatory Authority Head Office, Gaborone, Botswana
Off site: Audit/Inspection Visits to selected AMCs (e.g. Molepolole, Gaborone, Lobatse, Maun) selected Health Facilities, GVP MAH inspection site as per annual plan.
|
7. Travel - If travel is involved, full medical clearance is required |
The consultant is expected to travel to Gaborone, Botswana to conduct the assignment. All travel arrangements will be made by WHO. Travel within Botswana will be organized as per workplan
|
8. Remuneration and budget |
As per the WHO policy/guidelines. P4 level
|
9. Proposed Timelines |
Start date: 11th January 2027 End date: 9th April 2027 Total duration: 3 months
|
10. Roles and Responsibilities |
Consultant - Deliver agreed outputs - Maintain confidentiality - Develop GBT evidence review plan in collaboration with NRA
BoMRA - Provide access to documents, staff and facilities - Assign focal point - Facilitate meetings and logistics - Review GBT evidence review plan in collaboration with consultant
|
We review listings for quality, but organizations may update or amend a posting at any time, so confirm the role and closing date on the organization’s official site before applying. No genuine employer charges a fee to apply, interview, or process an application — treat any request for payment as a scam. If a detail looks wrong or the posting seems fraudulent, report this job.
